Concepedia

Publication | Closed Access

XELIRI or FOLFIRI as salvage therapy in advanced pancreatic cancer.

18

Citations

41

References

2010

Year

Stefano Cereda, Michele Reni, Alessia Rognone, Michele Ghidini, Carmen Belli, Simona Longoni, Clara Fugazza, Matteo Brioschi, Roberto Nicoletti, Gianpaolo Balzano,
PubMed

Abstract

Fluoropyrimidine and irinotecan combination does not seem to have any role in the treatment of gemcitabine-resistant PA.

References

YearCitations

Page 1